Loading...

Tag trends are in beta. Feedback? Thoughts? Email me at [email protected]

In a first for the field, all non-human primates given a new series of vaccines generated antibodies capable of fighting multiple strains of HIV.

Optimism may lower dementia risk | Harvard T.H. Chan School of Public Health

Antidepressants and antipsychotics could serve as alternatives to opioids, study finds

Clinical Trial: High Doses of CBD Superior to Placebo in Treating Neuropathic Pain

Statin Use Linked to Lower Risk of Frailty in Older Veterans

Study Confirms Safety of Pregnancy Painkillers: new research found taking paracetamol (Acamol/Tylenol) or Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as ibuprofen (Advil/Nurofen) does not increase the risk of birth defects

35% of older adults and half of adults under 50 now get now their health information from self-defined experts online

mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models

New GLP-1 Oral Pill Lowers Blood Sugar and Reduces Bodyweight

Police remove top researchers from ADA (diabetes conference) for passing out anti-Trump journal article. More in comments

Sinus venosus atrial defect correction using the “Z” flap technique has shorter ischemic times, but is associated with higher risk of developing postoperative junctional rhythms

Scientists have developed a vaccine that enables the immune system to swiftly neutralize fentanyl, and new emerging synthetic fentanyl analogs, before they reach the brain in the first place

Study reveals new target for treating sleep apnea

Article linking hepatitis B vaccines to autism is retracted by the Journal of Toxicology and Environmental Health because of critical methodological flaws

Podcast with some of the authors from The Lancet Special issue in Neurology: advances and challenges in the field

Genetically engineered hookworms can now secrete human therapeutic antibodies directly into their host's circulation, offering a potential single-dose, years-long drug delivery platform

New Benchmark Evaluates AI for Everyday Patient Care

Study: Patients With Hypermobility Disorders Experience Less Pain, Consume Fewer Opioids Following Medical Cannabis Treatment

One or two psilocybin doses still lifting depression a year on

Triple-action diabetes jab shown to reduce blood sugar and body weight

Elecoglipron, an oral GLP-1 drug taken daily, demonstrated clinically meaningful weight reductions in adults with obesity or overweight, in a new randomised, placebo-controlled clinical trial.

Case report: transient return of speech and continence in advanced dementia patient after 5g psilocybin mushrooms

Clinical Trial: Cannabis Oil Provides “Clinically Meaningful” Improvements in Fibromyalgia Symptoms

Researchers have successfully mimicked the electrical behavior of biological heart muscle cells using a new type of conductive plastic, paving the way for revolutionary bioelectronics and advanced treatments for cardiac diseases.

Researchers develop a real-time, bedside brain monitor that continuously analyzes cerebrospinal fluid for biomarkers

AI-designed universal coronavirus vaccine passes first human trial

World-first: therapy to make cells young again trialled in a person

Semaglutide, a GLP-1 weight loss drug, slowed biological aging across multiple epigenetic clocks in a randomized, double-blind, placebo-controlled clinical trial in patients with HIV, suggesting that the drug may influence aging-related biology across multiple body systems.

American Medical Association (AMA) Adopts Policy Pushing Back on AI Creep in Medicine

This sticky substance could be a rare example of Neanderthal medicine

More →